{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:38:49Z","timestamp":1790375929772,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.1038\/nm1201-1271","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:34:56Z","timestamp":1027658096000},"page":"1271-1273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Bioterrorism: A clear and present danger"],"prefix":"10.1038","volume":"7","author":[{"given":"H. Clifford","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John La","family":"Montagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Fauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm12011271_CR1","unstructured":"Anthrax case confirmed 63-year-old man hospitalized. The Associated Press. October 4, 2001."},{"key":"BFnm12011271_CR2","unstructured":"Ongoing investigation of anthrax\u2014Florida, October 2001. MMWR Morb. Mortal. Wkly. Rep. 50, 877 (2001)."},{"key":"BFnm12011271_CR3","unstructured":"Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. MMWR Morb. Mortal. Wkly. Rep. 50, 973\u2013976 (2001)."},{"key":"BFnm12011271_CR4","doi-asserted-by":"crossref","unstructured":"Jernigan, J.A. et al. Bioterrorism-related inhalation anthrax: The first 10 cases reported in the United States. Emerg. Infect. Dis . posted on-line 8 November 2001.(http:\/\/www.cdc.gov\/ncidod\/eid\/vol7no6\/jernigan.htm).","DOI":"10.3201\/eid0706.010604"},{"key":"BFnm12011271_CR5","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","volume":"281","author":"TV Inglesby","year":"1999","unstructured":"Inglesby, T.V. et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281, 1735\u20131745 (1999).","journal-title":"JAMA"},{"key":"BFnm12011271_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","volume":"167","author":"AM Friedlander","year":"1993","unstructured":"Friedlander, A.M. et al. Postexposure prophylaxis against experimental inhalation anthrax. J. Inf. Dis. 167, 1239\u20131242 (1993).","journal-title":"J. Inf. Dis."},{"key":"BFnm12011271_CR7","unstructured":"Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 49, RR-15 (2000)."},{"key":"BFnm12011271_CR8","first-page":"535","volume":"65","author":"DA Henderson","year":"1987","unstructured":"Henderson, D.A. Principles and lessons from the smallpox eradication programme. Bull. World Health Organ . 65, 535\u2013546 (1987).","journal-title":"Bull. World Health Organ"},{"key":"BFnm12011271_CR9","volume-title":"Biohazard: The Chilling Story of the Largest Covert Biological Weapons Program in the World\u2014Told from Inside by the Man Who Ran It","author":"K Alibek","year":"1999","unstructured":"Alibek, K. & Handelman, S. Biohazard: The Chilling Story of the Largest Covert Biological Weapons Program in the World\u2014Told from Inside by the Man Who Ran It. (Dell, New York, New York, USA, 1999)."},{"key":"BFnm12011271_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3201\/eid0504.9904029","volume":"5","author":"JW LeDuc","year":"1999","unstructured":"LeDuc, J.W. & Becher, J. Current status of smallpox vaccine. Emerg. Infect. Dis. 5, 593\u2013594 (1999).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnm12011271_CR11","first-page":"443","volume":"4","author":"OG Andzhaparidze","year":"1980","unstructured":"Andzhaparidze, O.G. et al. Investigation of tissue culture MNIIVP smallpox vaccine in a coded controlled trial by revaccination of adults by scarification. Vopr. Virusol. 4, 443\u2013446 (1980).","journal-title":"Vopr. Virusol."},{"key":"BFnm12011271_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.14.2.382-397.2001","volume":"14","author":"E De Clercq","year":"2001","unstructured":"De Clercq, E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clin. Microbiol. Rev. 14, 382\u2013397 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnm12011271_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/315190","volume":"181","author":"M Bray","year":"2000","unstructured":"Bray, M. et al. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J. Inf. Dis. 181, 10\u201319 (2000).","journal-title":"J. Inf. Dis."},{"key":"BFnm12011271_CR14","unstructured":"Analysis of the nucleotide sequences of variola virus genomes. Bull. World Health Organ. 72, 813\u2013814, 817\u2013818 (1994)."},{"key":"BFnm12011271_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJM199909093411107","volume":"341","author":"TC Dixon","year":"1999","unstructured":"Dixon, T.C., Meselson, M., Guillemin, J. & Hanna, P.C. Anthrax. N. Engl. J. Med . 341, 815\u2013826 (1999).","journal-title":"N. Engl. J. Med"},{"key":"BFnm12011271_CR16","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","volume":"264","author":"Y Singh","year":"1989","unstructured":"Singh, Y., Chaudhary, V.K. & Leppla, S.H. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J. Biol. Chem. 264, 19103\u201319107 (1989).","journal-title":"J. Biol. Chem."},{"key":"BFnm12011271_CR17","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","volume":"69","author":"S Reuveny","year":"2001","unstructured":"Reuveny, S. et al. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun. 69, 2888\u20132893 (2001).","journal-title":"Infect. Immun"},{"key":"BFnm12011271_CR18","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","volume":"282","author":"AM Friedlander","year":"1999","unstructured":"Friedlander, A.M., Pittman, P.R. & Parker, G.W. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282, 2104\u20132106 (1999).","journal-title":"JAMA"},{"key":"BFnm12011271_CR19","volume-title":"Abstracts Book","author":"LJ Thomas","year":"2001","unstructured":"Thomas, L.J. et al. An immunogenicity and reactogenicity evaluation of a recombinant Bacillus anthracis protective antigen vaccine. 4th International Conference on Anthrax. Abstracts Book June 10\u201313, 2001, Annapolis, Maryland, USA."},{"key":"BFnm12011271_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","volume":"13","author":"PCB Turnbull","year":"2000","unstructured":"Turnbull, P.C.B. Current status of immunization against anthrax: old vaccines may be here to stay for a while. Curr. Opin. Infect. Dis. 13, 113\u2013120 (2000).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"BFnm12011271_CR21","doi-asserted-by":"publisher","first-page":"22090","DOI":"10.1074\/jbc.M010222200","volume":"276","author":"Y Singh","year":"2001","unstructured":"Singh, Y., Khanna, H., Chopra, A.P. & Mehra, V. Dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo. J. Biol. Chem. 276, 22090\u201322094 (2001).","journal-title":"J. Biol. Chem"},{"key":"BFnm12011271_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","volume":"13","author":"KR Klimpel","year":"1994","unstructured":"Klimpel, K.R., Arora, N. & Leppla, S.H. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13, 1093\u20131100 (1994).","journal-title":"Mol. Microbiol."},{"key":"BFnm12011271_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/n35101998","volume":"414","author":"AD Pannifer","year":"2001","unstructured":"Pannifer, A.D. et al. Crystal structure of the anthrax lethal factor. Nature 414, 229\u2013233 (2001)","journal-title":"Nature"},{"key":"BFnm12011271_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/35046108","volume":"408","author":"NJ Sullivan","year":"2000","unstructured":"Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605\u2013609 (2000).","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/nm0102-87a","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1201-1271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1201-1271","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1201-1271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:02:45Z","timestamp":1744275765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1201-1271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12,1]]}},"alternative-id":["BFnm12011271"],"URL":"https:\/\/doi.org\/10.1038\/nm1201-1271","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12,1]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}